1. Home
  2. INSM vs NXPLW Comparison

INSM vs NXPLW Comparison

Compare INSM & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • NXPLW
  • Stock Information
  • Founded
  • INSM 1988
  • NXPLW N/A
  • Country
  • INSM United States
  • NXPLW United States
  • Employees
  • INSM N/A
  • NXPLW 166
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • NXPLW Telecommunications Equipment
  • Sector
  • INSM Health Care
  • NXPLW Telecommunications
  • Exchange
  • INSM Nasdaq
  • NXPLW Nasdaq
  • Market Cap
  • INSM N/A
  • NXPLW N/A
  • IPO Year
  • INSM 2000
  • NXPLW N/A
  • Fundamental
  • Price
  • INSM $70.44
  • NXPLW $0.10
  • Analyst Decision
  • INSM Strong Buy
  • NXPLW
  • Analyst Count
  • INSM 16
  • NXPLW 0
  • Target Price
  • INSM $84.29
  • NXPLW N/A
  • AVG Volume (30 Days)
  • INSM 1.9M
  • NXPLW N/A
  • Earning Date
  • INSM 02-20-2025
  • NXPLW N/A
  • Dividend Yield
  • INSM N/A
  • NXPLW N/A
  • EPS Growth
  • INSM N/A
  • NXPLW N/A
  • EPS
  • INSM N/A
  • NXPLW N/A
  • Revenue
  • INSM $342,958,000.00
  • NXPLW N/A
  • Revenue This Year
  • INSM $19.20
  • NXPLW N/A
  • Revenue Next Year
  • INSM $41.43
  • NXPLW N/A
  • P/E Ratio
  • INSM N/A
  • NXPLW N/A
  • Revenue Growth
  • INSM 22.13
  • NXPLW N/A
  • 52 Week Low
  • INSM $21.92
  • NXPLW N/A
  • 52 Week High
  • INSM $80.53
  • NXPLW N/A
  • Technical
  • Relative Strength Index (RSI)
  • INSM 44.64
  • NXPLW N/A
  • Support Level
  • INSM $68.67
  • NXPLW N/A
  • Resistance Level
  • INSM $75.16
  • NXPLW N/A
  • Average True Range (ATR)
  • INSM 2.82
  • NXPLW 0.00
  • MACD
  • INSM -0.49
  • NXPLW 0.00
  • Stochastic Oscillator
  • INSM 17.42
  • NXPLW 0.00

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: